ECSP034467A - Farmaceutico novedoso - Google Patents

Farmaceutico novedoso

Info

Publication number
ECSP034467A
ECSP034467A EC2003004467A ECSP034467A ECSP034467A EC SP034467 A ECSP034467 A EC SP034467A EC 2003004467 A EC2003004467 A EC 2003004467A EC SP034467 A ECSP034467 A EC SP034467A EC SP034467 A ECSP034467 A EC SP034467A
Authority
EC
Ecuador
Prior art keywords
compound
new pharmaceutical
pharmaceutical
dico
thiazolidin
Prior art date
Application number
EC2003004467A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ECSP034467A publication Critical patent/ECSP034467A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)

Abstract

Un compuesto novedoso farmacéutico DL-Tartrato de 5-[4-[2-(N- metil-N- (2- piridil)amino) etoxi]bencil]tiazolidin-2, 4-diona, a un solvato del mismo, un procedimiento para preparar dicho compuesto, una composición farmacéutica que comprende dicho compuesto y el uso de dico compuesto en medicina.
EC2003004467A 2000-08-04 2003-02-04 Farmaceutico novedoso ECSP034467A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ECSP034467A true ECSP034467A (es) 2003-03-31

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004467A ECSP034467A (es) 2000-08-04 2003-02-04 Farmaceutico novedoso

Country Status (36)

Country Link
US (1) US20040014790A1 (es)
EP (1) EP1305311B1 (es)
JP (1) JP2004505970A (es)
KR (1) KR100755174B1 (es)
CN (1) CN1455778A (es)
AP (1) AP1785A (es)
AT (1) ATE384059T1 (es)
AU (1) AU2001276506A1 (es)
BG (1) BG107604A (es)
BR (1) BR0112982A (es)
CA (1) CA2417827A1 (es)
CY (1) CY1107252T1 (es)
CZ (1) CZ2003313A3 (es)
DE (1) DE60132461T2 (es)
DK (1) DK1305311T3 (es)
DZ (1) DZ3418A1 (es)
EA (1) EA005408B1 (es)
EC (1) ECSP034467A (es)
ES (1) ES2296772T3 (es)
GB (1) GB0019224D0 (es)
HR (1) HRP20030068B1 (es)
HU (1) HUP0300778A3 (es)
IL (2) IL154275A0 (es)
MA (1) MA25832A1 (es)
MX (1) MXPA03001085A (es)
NO (1) NO324596B1 (es)
NZ (1) NZ524030A (es)
OA (1) OA12354A (es)
PL (1) PL360662A1 (es)
PT (1) PT1305311E (es)
SI (1) SI1305311T1 (es)
SK (1) SK1462003A3 (es)
UA (1) UA76720C2 (es)
WO (1) WO2002012232A1 (es)
YU (1) YU14603A (es)
ZA (1) ZA200300961B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP3367946B1 (en) 2015-10-27 2020-07-08 Nanopass Technologies Ltd. Microneedle device with mechanical guide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EA005408B1 (ru) 2005-02-24
ES2296772T3 (es) 2008-05-01
KR100755174B1 (ko) 2007-09-03
NZ524030A (en) 2004-07-30
EP1305311A1 (en) 2003-05-02
CZ2003313A3 (cs) 2004-02-18
HRP20030068A2 (en) 2005-02-28
US20040014790A1 (en) 2004-01-22
YU14603A (sh) 2006-05-25
DZ3418A1 (fr) 2002-02-14
NO20030530L (no) 2003-02-03
MXPA03001085A (es) 2003-05-27
NO20030530D0 (no) 2003-02-03
HUP0300778A3 (en) 2005-04-28
MA25832A1 (fr) 2003-07-01
EP1305311B1 (en) 2008-01-16
DE60132461T2 (de) 2008-12-24
AU2001276506A1 (en) 2002-02-18
CA2417827A1 (en) 2002-02-14
PL360662A1 (en) 2004-09-20
HUP0300778A2 (hu) 2003-11-28
HRP20030068B1 (en) 2008-07-31
PT1305311E (pt) 2008-04-07
DK1305311T3 (da) 2008-05-19
CN1455778A (zh) 2003-11-12
EA200300230A1 (ru) 2003-06-26
OA12354A (en) 2004-03-19
IL154275A (en) 2009-02-11
WO2002012232A1 (en) 2002-02-14
GB0019224D0 (en) 2000-09-27
DE60132461D1 (de) 2008-03-06
SK1462003A3 (en) 2004-06-08
IL154275A0 (en) 2003-09-17
BG107604A (bg) 2003-09-30
ZA200300961B (en) 2004-04-01
HK1057358A1 (en) 2004-04-02
AP1785A (en) 2007-10-04
CY1107252T1 (el) 2012-11-21
ATE384059T1 (de) 2008-02-15
BR0112982A (pt) 2003-08-26
KR20030022355A (ko) 2003-03-15
SI1305311T1 (sl) 2008-04-30
AP2003002736A0 (en) 2003-03-31
JP2004505970A (ja) 2004-02-26
UA76720C2 (uk) 2006-09-15
NO324596B1 (no) 2007-11-26

Similar Documents

Publication Publication Date Title
AR015894A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos
MY135973A (en) Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
AR015120A1 (es) Composicion farmaceutica que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino) etoxi]bencil]-tiazolidin-2,4-diona, un procedimiento para su preparacion, y unacomposicion para la pre-administracion farmaceutica
ECSP034469A (es) Compuesto farmaceutico novedoso
ECSP034468A (es) Compuesto farmaceutico novedoso
ECSP034505A (es) La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona
CY1107252T1 (el) Τρυγικο αλας παραγωγου της θειζολιδινοδιονης
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
ECSP034466A (es) Farmaceutico novedoso
GB0021784D0 (en) Novel pharmaceutical
EA200300004A1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
ECSP034529A (es) Derivado de tiazolidinodiona y su uso como antidiabetico
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
ECSP003435A (es) Nuevos compuestos
ECSP003434A (es) Nuevos compuestos
DK1448559T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel
AR018994A1 (es) Compuestos tiazolidindiona, un proceso para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento